The mouse strain O20 is highly resistant to parasite Leishmania major. O20 mice differed from all resistant strains tested until now, as they harbored parasites in their organs, but upon exposure to soluble Leishmania antigen (SLA) their splenocytes did not respond by cytokine production and their macrophages did not produce NO, suggesting a novel mechanism of resistance. Another resistant strain C57BL/10 (B10) harbors similar numbers of parasites as O20 in its organs and its splenocytes respond to SLA by production of IFNγ, but not IL-4. They also produce IL-2, IL-6, IL-10 and IL-17. Macrophages respond to SLA by NO production. Strain B10.O20 was derived from a cross of these two resistant strains. B10 provided 96.4% of its genome and O20 contributed 3.6% of its genome. Unexpectedly, this very limited difference between the two strains resulted in the very large phenotypic effects. B10.O20 was susceptible to L. major, as it exhibited large skin lesions, high parasite numbers in skin and lymph nodes, and a massive spleen infiltration by CD11b+CD193+ and CD11b+Gr1+ cells. Thus, a small percentage of genes of the resistant strain O20 in the genome of the second resistant strain B10 resulted in high susceptibility to L. major. After stimulation with SLA, splenocytes of B10.O20 produced significantly higher levels of all Th1, Th2 and Th17 cytokines than both its parental strains B10 and O20. This suggested a chronic inflammation with imbalance of several arms of immune response. In summary, the responses of strains B10.O20 and O20 to L. major revealed novel disease phenotypes that have not been observed previously in mice but they were seen in several clinical studies of human leishmaniasis. The studies of heterogeneity of defensive strategies of mouse strains may guide development of effective antileishmanial therapies or vaccine development and it could serve as a basis for investigation of asymptomatic responses to other infectious diseases.

Department of Cardiology 1 Coronary Peripheral Vascular Disease and Heart Failure University Hospital Münster University of Münster Münster Germany

Department of Medical Genetics 3rd Faculty of Medicine Charles University Prague Czechia

Department of Molecular and Cellular Biology Roswell Park Comprehensive Cancer Center Buffalo NY United States

Department of Parasitology Faculty of Science Charles University Prague Czechia

Department of Toxicology and Molecular Epidemiology Institute of Experimental Medicine of the Czech Academy of Sciences Prague Czechia

Laboratory of Leukocyte Signalling Institute of Molecular Genetics Czech Academy of Sciences Prague Czechia

Laboratory of Molecular and Cellular Immunology Institute of Molecular Genetics Czech Academy of Sciences Prague Czechia

Laboratory of Signal Transduction Institute of Molecular Genetics Czech Academy of Sciences Prague Czechia

Zobrazit více v PubMed

Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PloS One. (2012) 7:e35671. doi:  10.1371/journal.pone.0035671, PMID: PubMed DOI PMC

Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. (2018) 392:951–70. doi:  10.1016/S0140-6736(18)31204-2, PMID: PubMed DOI

WHO . Available online at: https://www.who.int/health-topics/leishmaniasistab=tab_1 (Accessed November 12, 2024).

Bamorovat M, Sharifi I, Khosravi A, Aflatoonian MR, Agha Kuchak Afshari S, Salarkia E, et al. Global dilemma and needs assessment toward achieving sustainable development goals in controlling leishmaniasis. J Epidemiol Glob Health. (2024) 14:22–34. doi:  10.1007/s44197-024-00190-z, PMID: PubMed DOI PMC

Bogdan C. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol. (2008) 10:1221–34. doi:  10.1111/j.1462-5822.2008.01146.x, PMID: PubMed DOI

Terrazas CA, Terrazas LI, Gómez-García L. Modulation of dendritic cell responses by parasites: a common strategy to survive. J BioMed Biotechnol. (2010) 2010:357106. doi:  10.1155/2010/357106, PMID: PubMed DOI PMC

Schwing A, Pisani DF, Pomares C, Majoor A, Lacas-Gervais S, Jager J, et al. Identification of adipocytes as target cells for PubMed DOI PMC

Dedet J-P. Current status of epidemiology of leishmaniases. In: Farrel JP, editor. Leishmania. Springer USA, Boston, MA: (2002). p. 1–10.

Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R, editors. The leishmaniases in biology and medicine. Volume I. Biology and Epidemiology. Academic Press, London: (1987), ISBN: ISBN 0 12 552101 4. p. 120.

Kobets T, Grekov I, Lipoldova M. Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem. (2012) 19:1443–74. doi:  10.2174/092986712799828300, PMID: PubMed DOI

King A. In search of a vaccine for leishmaniasis. Nature. (2023). doi:  10.1038/d41586-023-02580-y, PMID: PubMed DOI

Mandell MA, Beverley SM. Continual renewal and replication of persistent PubMed DOI PMC

Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, et al. Latent infection with PubMed DOI PMC

Singh OP, Sundar S. Whole blood assay and visceral leishmaniasis: Challenges and promises. Immunobiology. (2014) 219:323–8. doi:  10.1016/j.imbio.2014.01.005, PMID: PubMed DOI PMC

Singh OP, Hasker E, Sacks D, Boelaert M, Sundar S. Asymptomatic PubMed DOI PMC

Rock KS, Chapman LAC, Dobson AP, Adams ER, Hollingsworth TD. The hidden hand of asymptomatic infection hinders control of neglected tropical diseases: A modeling analysis. Clin Infect Dis. (2024) 78:S175–82. doi:  10.1093/cid/ciae096, PMID: PubMed DOI PMC

Aebischer T. Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol Today. (1994) 10:25–8. doi:  10.1016/0169-4758(94)90353-0, PMID: PubMed DOI

Tuon FF, Bombonatto GM, Battaglin ER, Sakumoto MH, Amato VS, de Camargo RA, et al. Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient. Am J Trop Med Hyg. (2014) 91:81–3. doi:  10.4269/ajtmh.13-0578, PMID: PubMed DOI PMC

Lipoldová M, Demant P. Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet. (2006) 7:294–305. doi:  10.1038/nrg1832, PMID: PubMed DOI

Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med. (2016) 9:925–32. doi:  10.1016/j.apjtm.2016.06.021, PMID: PubMed DOI

Blackwell JM, Fakiola M, Castellucci LC. Human genetics of PubMed DOI PMC

Lipoldová M, Demant P. Gene-specific sex effects on susceptibility to infectious diseases. Front Immunol. (2021) 12:712688. doi:  10.3389/fimmu.2021.712688, PMID: PubMed DOI PMC

Krayem I, Lipoldová M. Role of host genetics and cytokines in PubMed DOI

Bharati K. Human genetic polymorphism and Leishmaniasis. Infect Genet Evol. (2022) 98:105203. doi:  10.1016/j.meegid.2021.105203, PMID: PubMed DOI

Krayem I, Sohrabi Y, Havelková H, Gusareva ES, Strnad H, Čepičková M, et al. Functionally distinct regions of the locus PubMed DOI PMC

Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to PubMed DOI

Sakthianandeswaren A, Foote SJ, Handman E. The role of host genetics in leishmaniasis. Trends Parasitol. (2009) 25:383–91. doi:  10.1016/j.pt.2009.05.004, PMID: PubMed DOI

Loeuillet C, Bañuls AL, Hide M. Study of PubMed DOI PMC

Bogdan C. Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism. Cytokine X. (2020) 2:100041. doi:  10.1016/j.cytox.2020.100041, PMID: PubMed DOI PMC

Lipoldová M, Sohrabi Y. Role of interferon-induced GTPases in leishmaniasis. PloS Negl Trop Dis. (2022) 16:e0010093. doi:  10.1371/journal.pntd.0010093, PMID: PubMed DOI PMC

Mock BA, Fortier AH, Potter M, Nacy CA. Genetic control of systemic PubMed DOI PMC

Sacks D, Anderson C. Re-examination of the immunosuppressive mechanisms mediating non-cure of PubMed DOI

Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med. (1989) 169:59–72. doi:  10.1084/jem.169.1.59, PMID: PubMed DOI PMC

Liew FY. Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol Today. (1989) 10:40–5. doi:  10.1016/0167-5699(89)90302-2, PMID: PubMed DOI

Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S. Macrophage killing of PubMed DOI

Shankar AH, Titus RG. T cell and non-T cell compartments can independently determine resistance to PubMed DOI PMC

Nylén S, Gautam S. Immunological perspectives of leishmaniasis. J Glob Infect Dis. (2010) 2:135–46. doi:  10.4103/0974-777X.62876, PMID: PubMed DOI PMC

Ashok D, Acha-Orbea H. Timing is everything: dendritic cell subsets in murine PubMed DOI

Moll H. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunol Today. (1993) 14:383–7. doi:  10.1016/0167-5699(93)90138-B, PMID: PubMed DOI

Charmoy M, Brunner-Agten S, Aebischer D, Auderset F, Launois P, Milon G, et al. Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of PubMed DOI PMC

Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, Launois P, et al. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with PubMed DOI

Ehrchen JM, Roebrock K, Foell D, Nippe N, von Stebut E, Weiss JM, et al. Keratinocytes determine Th1 immunity during early experimental leishmaniasis. PloS Pathog. (2010) 6:e1000871. doi:  10.1371/journal.ppat.1000871, PMID: PubMed DOI PMC

Schmid M, Zimara N, Wege AK, Ritter U. Myeloid-derived suppressor cell functionality and interaction with PubMed DOI

Rashidi S, Mansouri R, Ali-Hassanzadeh M, Ghani E, Barazesh A, Karimazar M, et al. Highlighting the interplay of microRNAs from PubMed DOI PMC

Demant P, Lipoldova M, Svobodova M. Resistance to PubMed DOI

Beebe AM, Mauze S, Schork NJ, Coffman RL. Serial backcross mapping of multiple loci associated with resistance to PubMed DOI

Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ. Resistance to PubMed DOI PMC

Slapničková M, Volkova V, Čepičková M, Kobets T, Šíma M, Svobodová M, et al. Gene-specific sex effects on eosinophil infiltration in leishmaniasis. Biol Sex Differ. (2016) 7:59. doi:  10.1186/s13293-016-0117-3, PMID: PubMed DOI PMC

Kobets T, Čepičková M, Volkova V, Sohrabi Y, Havelková H, Svobodová M, et al. Novel loci controlling parasite load in organs of mice infected with PubMed DOI PMC

Kedzierski L, Evans KJ. Immune responses during cutaneous and visceral leishmaniasis. Parasitology. (2014) 141(12):1544–62. doi:  10.1017/S003118201400095X, PMID: PubMed DOI

Mohan S, Revill P, Malvolti S, Malhame M, Sculpher M, Kaye PM. Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates. PloS Negl Trop Dis. (2022) 16:e0010471. doi:  10.1371/journal.pntd.0010471, PMID: PubMed DOI PMC

Nagill R, Kaur S. Vaccine candidates for leishmaniasis: a review. Int Immunopharmacol. (2011) 11:1464–88. doi:  10.1016/j.intimp.2011.05.008, PMID: PubMed DOI

Silver LM. Mouse genetics: concepts and applications. Oxford, New York: Oxford University Press; (1995).

Stassen AP, Groot PC, Eppig JT, Demant P. Genetic composition of the recombinant congenic strains. Mamm Genome. (1996) 7:55–8. doi:  10.1007/s003359900013, PMID: PubMed DOI

Krayem I, Sohrabi Y, Javorková E, Volkova V, Strnad H, Havelková H, et al. Genetic influence on frequencies of myeloid-derived cell subpopulations in mouse. Front Immunol. (2022) 12:760881. doi:  10.3389/fimmu.2021.760881, PMID: PubMed DOI PMC

Grekov I, Svobodová M, Nohýnková E, Lipoldová M. Preparation of highly infective PubMed DOI

Lipoldová M, Svobodová M, Krulová M, Havelková H, Badalová J, Nohýnková E, et al. Susceptibility to PubMed DOI

Kobets T, Badalová J, Grekov I, Havelková H, Svobodová M, Lipoldová M. PubMed DOI

Khamesipour A, Nateghi Rostami M, Tasbihi M, Miramin Mohammadi A, Shahrestani T, Sarrafnejad A, et al. Phenotyping of circulating CD8 PubMed DOI

Holan V, Cervena T, Zajicova A, Hermankova B, Echalar B, Palacka K, et al. The impact of metal nanoparticles on the immunoregulatory and therapeutic properties of mesenchymal stem cells. Stem Cell Rev Rep. (2023) 19:1360–9. doi:  10.1007/s12015-022-10500-2, PMID: PubMed DOI

Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. (1982) 126:131–8. doi:  10.1016/0003-2697(82)90118-x, PMID: PubMed DOI

Démant P, Hart AA. Recombinant congenic strains–a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics. (1986) 24:416–22. doi:  10.1007/BF00377961, PMID: PubMed DOI

Xu J, Gontier G, Chaker Z, Lacube P, Dupont J, Holzenberger M. Longevity effect of IGF-1R(+/-) mutation depends on genetic background-specific receptor activation. Aging Cell. (2014) 13:19–28. doi:  10.1111/acel.12145, PMID: PubMed DOI PMC

Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. (1995) 269:230–4. doi:  10.1126/science.7618084, PMID: PubMed DOI

Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity. (2000) 13:277–85. doi:  10.1016/s1074-7613(00)00027-3, PMID: PubMed DOI

Shinzawa M, Maruyama Y, Qin J, Akiyama N, Miyauchi M, Yanai H, et al. Splenic extramedullary hemopoiesis caused by a dysfunctional mutation in the NF-κB-inducing kinase gene. Biochem Biophys Res Commun. (2011) 414:773–8. doi:  10.1016/j.bbrc.2011.10.001, PMID: PubMed DOI

Howard JG, Hale C, Chan-Liew WL. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to PubMed DOI

Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, Lemieux S, et al. Epistasis between mouse PubMed DOI PMC

Guler R, Afshar M, Arendse B, Parihar SP, Revaz-Breton M, Leitges M, et al. PKCδ regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis. Eur J Immunol. (2011) 41:706–15. doi:  10.1002/eji.201040985, PMID: PubMed DOI

Heinzel FP, Rerko RM, Hujer AM, Maier RA, Jr. Increased capacity for interleukin-2 synthesis parallels disease progression in mice infected with PubMed DOI PMC

Muraille E, De Trez C, Brait M, De Baetselier P, Leo O, Carlier Y, et al. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to PubMed DOI

Panaro MA, Brandonisio O, Acquafredda A, Sisto M, Mitolo V. Evidences for iNOS expression and nitric oxide production in the human macrophages. Curr Drug Targets Immune Endocr Metabol Disord. (2003) 3:210–21. doi:  10.2174/1568008033340216, PMID: PubMed DOI

Lopez Kostka S, Dinges S, Griewank K, Iwakura Y, Udey MC, von Stebut E. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol. (2009) 182:3039–46. doi:  10.4049/jimmunol.0713598, PMID: PubMed DOI PMC

Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, et al. Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clin Exp Immunol. (2005) 140:349–53. doi:  10.1111/j.1365-2249.2005.02768.x, PMID: PubMed DOI PMC

Kammoun-Rebai W, Naouar I, Libri V, Albert M, Louzir H, Meddeb-Garnaoui A, et al. Protein biomarkers discriminate PubMed DOI PMC

Sassi A, Louzir H, Ben Salah A, Mokni M, Ben Osman A, Dellagi K. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic PubMed DOI PMC

Costa AS, Costa GC, Aquino DM, Mendonça VR, Barral A, Barral-Netto M, et al. Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis. Mem Inst Oswaldo Cruz. (2012) 107:735–9. doi:  10.1590/s0074-02762012000600005, PMID: PubMed DOI

Peruhype-Magalhães V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, Teixeira-Carvalho A, et al. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to PubMed DOI PMC

Kong YY, Fuchsberger M, Xiang SD, Apostolopoulos V, Plebanski M. Myeloid derived suppressor cells and their role in diseases. Curr Med Chem. (2013) 20:1437–44. doi:  10.2174/0929867311320110006, PMID: PubMed DOI

Pereira WF, Ribeiro-Gomes FL, Guillermo LV, Vellozo NS, Montalvão F, Dosreis GA, et al. Myeloid-derived suppressor cells help protective immunity to PubMed DOI

Banus S, Vandebriel RJ, Pennings JL, Gremmer ER, Wester PW, van Kranen HJ, et al. Comparative gene expression profiling in two congenic mouse strains following PubMed DOI PMC

Ghosh J, Das S, Guha R, Ghosh D, Naskar K, Das A, et al. Hyperlipidemia offers protection against PubMed DOI PMC

Netea MG, Domínguez-Andrés J, van de Veerdonk FL, van Crevel R, Pulendran B, van der Meer JWM. Natural resistance against infections: focus on COVID-19. Trends Immunol. (2021) 43(2):106–16. doi:  10.1016/j.it.2021.12.001, PMID: PubMed DOI PMC

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team . The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Wkly. (2020) 2:113–22. PubMed PMC

Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. (2020) 25:2000180. doi:  10.2807/1560-7917.ES.2020.25.10.2000180, PMID: PubMed DOI PMC

Qi R, Huang YT, Liu JW, Sun Y, Sun XF, Han HJ, et al. Global prevalence of asymptomatic norovirus infection: A meta-analysis. EClinicalMedicine. (2018) 2-3:50–8. doi:  10.1016/j.eclinm.2018.09.001, PMID: PubMed DOI PMC

Kendall EA, Kitonsa PJ, Nalutaaya A, Erisa KC, Mukiibi J, Nakasolya O, et al. The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities. Clin Infect Dis. (2021) 72:e1035–e43. doi:  10.1093/cid/ciaa1824, PMID: PubMed DOI PMC

da Silva-Nunes M, Ferreira MU. Clinical spectrum of uncomplicated malaria in semi-immune Amazonians: beyond the “ symptomatic “ vs “ asymptomatic “ dichotomy. Mem Inst Oswaldo Cruz. (2007) 102:341–7. doi:  10.1590/s0074-02762007005000051, PMID: PubMed DOI

Paris L. 106 - toxoplasmosis. In: Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP, editors. Hunter’s Tropical Medicine and Emerging Infectious Diseases (Tenth Edition). Elsevier, London: (2020). p. 803–13.

Laishram DD, Sutton PL, Nanda N, Sharma VL, Sobti RC, Carlton JM, et al. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J. (2012) 11:29. doi:  10.1186/1475-2875-11-29, PMID: PubMed DOI PMC

Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. (2013) 11:623–39. doi:  10.1586/eri.13.45, PMID: PubMed DOI

Missinou MA, Lell B, Kremsner PG. Uncommon asymptomatic PubMed DOI

Garcia G, Sierra B, Perez AB, Aguirre E, Rosado I, Gonzalez N, et al. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg. (2010) 82:1153–6. doi:  10.4269/ajtmh.2010.09-0353, PMID: PubMed DOI PMC

Ahouty B, Koffi M, Ilboudo H, Simo G, Matovu E, Mulindwa J, et al. Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Cote d’Ivoire. PloS Negl Trop Dis. (2017) 11:e0005992. doi:  10.1371/journal.pntd.0005992, PMID: PubMed DOI PMC